Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Author's Takes
  • Reviews
    • View all reviews ...
    • Immune Environment in Glioblastoma (Feb 2023)
    • Korsmeyer Award 25th Anniversary Collection (Jan 2023)
    • Aging (Jul 2022)
    • Next-Generation Sequencing in Medicine (Jun 2022)
    • New Therapeutic Targets in Cardiovascular Diseases (Mar 2022)
    • Immunometabolism (Jan 2022)
    • Circadian Rhythm (Oct 2021)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Commentaries
    • Research letters
    • Letters to the editor
    • Editorials
    • Viewpoint
    • Top read articles
  • Clinical Medicine
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Author's Takes
  • In-Press Preview
  • Commentaries
  • Research letters
  • Letters to the editor
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
Sirt1 activation protects the mouse renal medulla from oxidative injury
Wenjuan He, … , Matthew D. Breyer, Chuan-Ming Hao
Wenjuan He, … , Matthew D. Breyer, Chuan-Ming Hao
Published March 24, 2010
Citation Information: J Clin Invest. 2010;120(4):1056-1068. https://doi.org/10.1172/JCI41563.
View: Text | PDF
Research Article

Sirt1 activation protects the mouse renal medulla from oxidative injury

  • Text
  • PDF
Abstract

Sirtuin 1 (Sirt1) is a NAD+-dependent deacetylase that exerts many of the pleiotropic effects of oxidative metabolism. Due to local hypoxia and hypertonicity, the renal medulla is subject to extreme oxidative stress. Here, we set out to investigate the role of Sirt1 in the kidney. Our initial analysis indicated that it was abundantly expressed in mouse renal medullary interstitial cells in vivo. Knocking down Sirt1 expression in primary mouse renal medullary interstitial cells substantially reduced cellular resistance to oxidative stress, while pharmacologic Sirt1 activation using either resveratrol or SRT2183 improved cell survival in response to oxidative stress. The unilateral ureteral obstruction (UUO) model of kidney injury induced markedly more renal apoptosis and fibrosis in Sirt1+/– mice than in wild-type controls, while pharmacologic Sirt1 activation substantially attenuated apoptosis and fibrosis in wild-type mice. Moreover, Sirt1 deficiency attenuated oxidative stress–induced COX2 expression in cultured mouse renal medullary interstitial cells, and Sirt1+/– mice displayed reduced UUO-induced COX2 expression in vivo. Conversely, Sirt1 activation increased renal medullary interstitial cell COX2 expression both in vitro and in vivo. Furthermore, exogenous PGE2 markedly reduced apoptosis in Sirt1-deficient renal medullary interstitial cells following oxidative stress. Taken together, these results identify Sirt1 as an important protective factor for mouse renal medullary interstitial cells following oxidative stress and suggest that the protective function of Sirt1 is partly attributable to its regulation of COX2 induction. We therefore suggest that Sirt1 provides a potential therapeutic target to minimize renal medullary cell damage following oxidative stress.

Authors

Wenjuan He, Yingying Wang, Ming-Zhi Zhang, Li You, Linda S. Davis, Hong Fan, Hai-Chun Yang, Agnes B. Fogo, Roy Zent, Raymond C. Harris, Matthew D. Breyer, Chuan-Ming Hao

×

Figure 9

COX2 activity and its derived PGE2 protect cultured RMICs from oxidative stress.

Options: View larger image (or click on image) Download as PowerPoint
COX2 activity and its derived PGE2 protect cultured RMICs from oxidative...
(A and B) Wild-type or Sirt1-knockdown cultured RMICs were pretreated with the COX2 selective inhibitor SC58236 (0.5 μM, 2.5 μM) or PGE2 (100 nM, 1 μM) and challenged with H2O2 (250 μM) for 12 hours. Cell viability was examined by crystal violet staining (n = 6; *P < 0.0001 versus cells with H2O2 alone; †P < 0.0001 versus Sirt1-knockdown cells with H2O2 without PGE2; ‡P < 0.05 versus Sirt1-knockdown cells with H2O2 and 100 nM PGE2). (C and D) Wild-type or Sirt1-knockdown RMICs were pretreated with SC58236 (2.5 μM) or PGE2 (100 nM) and challenged with H2O2 (500 μM) for 6 hours. Cell apoptosis was examined by TUNEL assay (n = 15; *P < 0.001 versus cells with H2O2 alone; †P < 0.05 versus Sirt1-knockdown cells with H2O2 without PGE2). (E) Wild-type or Sirt1-knockdown RMICs were pretreated with 100 nM PGE2 and challenged with H2O2 (500 μM) for 6 hours. Expression of the cellular apoptosis marker cleaved caspase-3 was examined by immunoblot (n = 4, densitometry, *P < 0.05 versus Sirt1-knockdown cells with H2O2 without PGE2).

Copyright © 2023 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts